1-6 of 6
Joëlle Guilhot
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I/II Study of Escalating Doses of Idarubicin Orally Given with Oral Cyclophosphamide, Etoposide, Prednisolone and Intravenous Rituximab in Elderly Patients with Disseminated High Grade Non Hodgkin Lymphoma.

Amélie Fauveau, PharmD, Laurence Lacotte-Thierry, MD, Emmanuel Fleck, MD, Jean Yves Colin, MD, François Guilhot, MD, Michèle Chabin, PharmD, Alice Langlois, CRA, Joëlle Guilhot, MSci, Vincent Delwail, MD
Journal: Blood
Blood (2009) 114 (22): 3695.
https://doi.org/10.1182/blood.V114.22.3695.3695
Published: 2009
Journal Articles

Correlations between BCR-ABL Ratio and Cytogenetic Response at Months 12 of the Randomized French SPIRIT Study on Behalf the Fi-LMC Group.

Claude Preudhomme, MD, PhD, Catherine Roche-Lestienne, MD/PHD, Antoine Crinquette, MD, Christophe Roumier, MD/PHD, Virginie Eclache, MD, Joëlle Guilhot, MD, Francois Guilhot, MD/PHD, François-Xavier Mahon, MD/PHD
Journal: Blood
Blood (2006) 108 (11): 2150.
https://doi.org/10.1182/blood.V108.11.2150.2150
Published: 2006
Journal Articles

First Overall Molecular Response of the Randomized French SPIRIT Study on Behalf the Fi-LMC Group.

Catherine Roche-Lestienne, MD, PhD, François-Xavier Mahon, MD/PHD, Antoine Crinquette, MD, Joëlle Guilhot, PhD, Francois Guilhot, MD/PHD, Claude Preudhomme, MD/PHD
Journal: Blood
Blood (2006) 108 (11): 2151.
https://doi.org/10.1182/blood.V108.11.2151.2151
Published: 2006
Journal Articles

Survival advantage from imatinib compared with the combination interferon-α plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials

Clinical Trials & Observations
Lydia Roy, Joëlle Guilhot, Tillmann Krahnke, Agnès Guerci-Bresler, Brian J. Druker, Richard A. Larson, Steve O'Brien, Charlene So, Giorgio Massimini, François Guilhot
Journal: Blood
Blood (2006) 108 (5): 1478–1484.
https://doi.org/10.1182/blood-2006-02-001495
Published: 2006
Journal Articles

Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase

Clinical Trials & Observations
Martine Gardembas, Philippe Rousselot, Michel Tulliez, Magda Vigier, Agnès Buzyn, Françoise Rigal-Huguet, Laurence Legros, Mauricette Michallet, Christian Berthou, Nathalie Cheron, Frederic Maloisel, François-Xavier Mahon, Thierry Facon, Patrice Berthaud, Joëlle Guilhot, François Guilhot, for the CML French Group (FIϕLMC)
Journal: Blood
Blood (2003) 102 (13): 4298–4305.
https://doi.org/10.1182/blood-2003-04-1010
Published: 2003
Journal Articles

Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders

Clinical Trials & Observations
Francesca Bonifazi, Antonio de Vivo, Gianantonio Rosti, François Guilhot, Joëlle Guilhot, Elena Trabacchi, Rüdiger Hehlmann, Andreas Hochhaus, Patricia C. A. Shepherd, Juan Luis Steegmann, Hanneke C. Kluin-Nelemans, Josef Thaler, Bengt Simonsson, Andries Louwagie, Josy Reiffers, François Xavier Mahon, Enrico Montefusco, Giuliana Alimena, Joerg Hasford, Sue Richards, Giuseppe Saglio, Nicoletta Testoni, Giovanni Martinelli, Sante Tura, Michele Baccarani
Journal: Blood
Blood (2001) 98 (10): 3074–3081.
https://doi.org/10.1182/blood.V98.10.3074
Published: 2001